Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intra-Cellular Ther (ITCI)

Intra-Cellular Ther (ITCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Intra-Cellular T Has Returned 10.3% Since SmarTrend Recommendation (ITCI)

SmarTrend identified an Uptrend for Intra-Cellular T (NASDAQ:ITCI) on October 29th, 2019 at $8.92. In approximately 1 month, Intra-Cellular T has returned 10.26% as of today's recent price of $9.84.

ITCI : 10.20 (+3.98%)
Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that the Company will be...

ITCI : 10.20 (+3.98%)
Relatively Good Performance Detected in Shares of Intra-Cellular T in the Pharmaceuticals Industry (ITCI , NKTR , DERM , ZGNX , PFE )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 7.88 (-0.13%)
ITCI : 10.20 (+3.98%)
NKTR : 20.45 (+2.97%)
Watch for Intra-Cellular T to Potentially Pullback After Gaining 4.54% Yesterday

Intra-Cellular T (NASDAQ:ITCI) traded in a range yesterday that spanned from a low of $9.58 to a high of $10.01. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of...

ITCI : 10.20 (+3.98%)
Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock

Investors need to pay close attention to Intra-Cellular Therapies (ITCI) stock based on the movements in the options market lately.

ITCI : 10.20 (+3.98%)
Top Ranked Momentum Stocks to Buy for November 11th

Top Ranked Momentum Stocks to Buy for November 11th

LUNA : 7.55 (+0.94%)
ITCI : 10.20 (+3.98%)
FLGT : 11.83 (+1.98%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , SUPN , MDCO , PRGO , CTLT )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 10.20 (+3.98%)
MDCO : 84.21 (+0.37%)
SUPN : 22.83 (+3.96%)
Intra-Cellular: 3Q Earnings Snapshot

NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Tuesday reported a loss of $34.9 million in its third quarter.

ITCI : 10.20 (+3.98%)
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today provided a corporate update and announced...

ITCI : 10.20 (+3.98%)
Intra-Cellular Therapies Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Intra-Cellular Therapies.

ITCI : 10.20 (+3.98%)
Intra-Cellular Therapies to Host Third Quarter 2019 Financial Results Conference Call and Webcast

Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference...

ITCI : 10.20 (+3.98%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Intra-Cellular T (ITCI , HZNP , ZTS , LCI , LLY )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

HZNP : 32.23 (+1.16%)
ITCI : 10.20 (+3.98%)
ZTS : 121.72 (+1.34%)
Relatively Good Performance Detected in Shares of Nektar Therapeut in the Pharmaceuticals Industry (NKTR , ITCI , RVNC , PCRX , LCI )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ITCI : 10.20 (+3.98%)
NKTR : 20.45 (+2.97%)
RVNC : 16.31 (+2.39%)
Shares of Intersect Ent In Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (XENT , ITCI , MDCO , AGN , LLY )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

XENT : 21.11 (-1.36%)
ITCI : 10.20 (+3.98%)
MDCO : 84.21 (+0.37%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , LCI , DERM , JNJ , MDCO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 7.88 (-0.13%)
ITCI : 10.20 (+3.98%)
LCI : 8.80 (+3.65%)
Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference

Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D.,...

ITCI : 10.20 (+3.98%)
Are Options Traders Betting on a Big Move in Intra-Cellular Therapies (ITCI) Stock?

Investors need to pay close attention to Intra-Cellular Therapies (ITCI) stock based on the movements in the options market lately.

ITCI : 10.20 (+3.98%)
Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure

Data indicate ITI-214 at a dose of 30 mg is well tolerated with a favorable safety profile

ITCI : 10.20 (+3.98%)
6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day

Here we discuss six small-cap companies with promising candidates in their pipeline for Alzheimer's disease.

ITCI : 10.20 (+3.98%)
VTVT : 1.49 (-0.67%)
INMB : 5.20 (-0.17%)
ACIU : 8.78 (+7.20%)
ALEC : 19.76 (+1.91%)
SAVA : 1.79 (-0.56%)
Paratek Pharmace has the Best Relative Performance in the Pharmaceuticals Industry (PRTK , ITCI , PRGO , CTLT , MDCO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 10.20 (+3.98%)
PRTK : 3.06 (+2.00%)
PRGO : 52.29 (+0.93%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.46 , AIZ +1.17 , SBAC +0.55 , SO -0.62 , WELL -0.29
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar